(Q42703146)

5 November 2017

title

Phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors (English)

1 reference

5 November 2017

main subject

phase II clinical trial

0 references

palbociclib

1 reference

ChEBI release 2020-05-28

1 reference

David J Vaughn

1

1 reference

5 November 2017

Wei-Ting Hwang

2

1 reference

5 November 2017

Priti Lal

3

1 reference

5 November 2017

Mark A Rosen

4

1 reference

5 November 2017

Maryann Gallagher

5

1 reference

5 November 2017

Peter J O'Dwyer

6

1 reference

5 November 2017

language of work or name

English

0 references

publication date

18 December 2014

1 reference

5 November 2017

1 reference

5 November 2017

volume

121

1 reference

5 November 2017

issue

9

1 reference

5 November 2017

page(s)

1463-1468

1 reference

Medical treatment of advanced testicular cancer.

5 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

Towards the definition of the best management and prognostic factors of teratoma with malignant transformation: a single-institution case series and new proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

Chemotherapy for teratoma with malignant transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

Correlation between retinoblastoma gene expression and differentiation in human testicular tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

Deregulation of the RB pathway in human testicular germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

Treatment of growing teratoma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

Optimal two-stage designs for phase II clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

The growing teratoma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

inferred from DOI database lookup

7 January 2021

based on heuristic

Late relapse of testicular cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

inferred from DOI database lookup

7 January 2021

based on heuristic

Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29213

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.29213

1 reference

5 November 2017

1 reference